According to the Zhitong Finance App, Australian and Chinese Endoscopy (688212.SH) disclosed the 2026 third quarter report. The company achieved revenue of 455 million yuan in the first three quarters, an increase of 7.62% over the previous year. Net profit loss to mother was 97.85 million yuan, after deducting loss of 104 million yuan in non-net profit; basic earnings per share were -0.73 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.